. Author manuscript; available in PMC: 2012 Jul 1.

Published in final edited form as: Psychoneuroendocrinology. 2011 Dec 14;37(7):917–928. doi: 10.1016/j.psyneuen.2011.10.008

Table 2.

Treatment outcomes of telomerase activity with intention to treat and treatment efficacy analyses.

	Treatment			Control		T – C	p values
	N (t, c)	Pre (M ± SD)	Post (M ± SD)	Pre (M ± SD)	Post (M ± SD)	Mean diff. (95% CI)	Time	Group	Time× group
Intent-to-treat (ln)	19	1.73 ± 0.4	1.97 ± 0.4	1.82 ± 0.4	1.97 ± 0.3	0.10 (−0.2 to 0.4)	.004	.64	.45
Raw values	18	5.99 ± 2.2	7.67 ± 2.8	6.49 ± 2.7	7.51 ± 2.5	0.66 (−1.2 to 2.5)	.006	.81	.47
As-treated (ln)	17	1.67 ± 0.3	1.98 ± 0.4	1.84 ± 0.4	1.98 ± 0.3	0.16 (−0.1 to 0.4)	.001	.43	.21
Raw values	17	5.62 ± 2.0	7.81 ± 3.0	6.59 ± 2.8	7.63 ± 2.5	1.15 (−0.7 to 3.0)	.001	.60	.22